BMGL
BMGL
NASDAQ · Health Care

Basel Medical Group Ltd

$0.59
+0.04 (+7.53%)
Financial Highlights (FY 2026)
Revenue
11.99M
Net Income
-12,796,877
Gross Margin
Profit Margin
-106.8%
Rev Growth
+2.0%
D/E Ratio
0.70
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.9% 38.9%
Operating Margin -96.1% -86.5% 11.9% 13.4%
Profit Margin -106.8% -101.4% 11.7% 11.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.99M 11.75M 6.80M 6.40M
Gross Profit 2.64M 2.49M
Operating Income -11,516,758 -10,158,857 808.2K 856.0K
Net Income -12,796,877 -11,288,042 795.8K 756.4K
Gross Margin 38.9% 38.9%
Operating Margin -96.1% -86.5% 11.9% 13.4%
Profit Margin -106.8% -101.4% 11.7% 11.8%
Rev Growth +2.0% +2.0% -8.5% +14.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.38M 2.38M 4.33M 4.62M
Total Equity 3.39M 3.39M 8.88M 9.45M
D/E Ratio 0.70 0.70 0.49 0.49
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -11,862,073 -11,044,760 1.21M 1.15M
Free Cash Flow 635.1K 614.1K